Why would GH be worth $1 billion but Cybin is only 20% of that value. Yes, GH solid data but Cybin had better results for their P2. Maybe someone can explain?

Spravato, not that effective ?Meta-analysis. 3 screenshot attached.

Tryp Therapeutics: Q4 2024 Update

Doug's touching and inspirational post on LinkedIn, as to why he is so motivated to make this work with Cybin

Doug's touching and inspirational post on LinkedIn, as to why he is so motivated to make this work with Cybin 🙏👍

Doug's touching and inspirational post on LinkedIn, as to why he is so motivated to make this work with Cybin 🙏👍

Interview: "Doug Drysdale's Surprising Mental Health Discovery"

Cybin and the Terrible, Horrible, No Good, Very Bad year for the stock 💩💩💩💩💩💩

Weren't we told that with the 1 for 38 reverse split that big institutions and funds will be able to buy the stock ? Well, where are they ??

Tryp Therapeutics (ASX:TYP) is making headway in tackling Irritable Bowel Syndrome (IBS)

Predict a stock that will 10x in 2025

CYBIN Directors buying options to the tune of 748, 395 USD

Directors buying options to the tune of 748, 395 USD

Getting to Market

Who is the real conspiracy theorist ?

Tang Capital bought 1,105,433 shares yesterday

Phase 2 results

Tryp Therapeutics successfully completes Phase 1b study with TRP-8803 for Binge Eating Disorder.

Phase 3

Tryp (TYP:AX) to advance TRP8803 (IV infused Psilocin) to P2 clinical trials

Did anyone buy Tryp Therapeutics (TYP:AX) when I posted about them 2 weeks ago ?

Cybin - now: "cash to go to topline data" & "we will likely need to raise more"

Anyone buy the dip last week?

My Take: Why LSD is the winner in the Pharmaceutical Space.

My Take: Why LSD is the winner in the Pharmaceutical Space.

Tryp Therapeutics begins Phase 1b study with TRP-8803 for Binge Eating Disorder.